In-House Health has formally launched its AI-driven scheduling and management platform for modern nursing teams. The company recently raised $4 million in seed funding, led by NEA and TMV, with participation from pre-seed investors Vine Ventures and Longevity Venture Partners. This brings the total investment to date to $5.4 million.
In-House Health was launched in 2023 by two healthcare professionals and a technical leader: Ari Brenner, Sergey Vasilenko, and Shachar Har Zvi. Brenner previously worked as the Co-Founder and COO of Stellar Health (a healthcare technology company that works with payors and health systems to manage their value-based activities). Vasilenko was a former critical care nurse who transitioned to EMR/clinical informatics. Har Zvi joined the company from Google as a Technical Lead. In-House Health was born based on firsthand experiences with inefficiencies in hospital staff management and how they could be solved through technology.
Nurse team leaders spend 15+ hours a week managing shift schedules, buried in repetitive drag-and-drop screens or even pen, paper, and whiteboards. And while many hospitals typically employ thousands of employees, they often operate as regional silos. As a result, they face unpredictable demands and challenges managing their employees while constantly playing catch-up in response to changing circumstances.
In-House Health addresses these challenges by working closely with hospitals and providers to streamline staffing workflows. Its AI algorithm is trained on millions of patient records to identify patterns of bedside care and anticipate shift changes weeks earlier than is normally possible. So, the algorithm can shorten hours spent on scheduling by half or more and reduce labor costs by over 10% across the board amid the growing crisis of workforce shortages and spiraling costs to deliver care.
In-House experienced quick adoption from hospital executives and bedside nurses alike. And its system currently delivers scheduling and clinical insights to the management of over 800 nurses.
KEY QUOTES:
“Saving manager time on scheduling is a huge win and relieves burnout among nursing leaders, but the real prize is improved staffing outcomes,” explained Brenner. “When hospitals fail to properly predict the future, it costs money in overtime pay and agency use. We can reduce both through precision staffing.”
- Ari Brenner
“In-House’s platform makes it easy for hospitals to schedule adaptively. This unlocks control over schedule and flexibility that is now critical to keep nurses satisfied and reduce burnout associated with last-minute changes.”
- James Kerridge, DNP, Associate Chief Nurse, Chicago VA Medical Center and Board Member with the Illinois Organization of Nurse Leaders, who joined In-House’s Nursing Advisory Board more than a year ago to help shape its product and clinical strategy
“At NEA, across our current and historical portfolio, we have deep experience across healthcare staffing markets. While there have been prior attempts to disrupt this market, we believe In-House’s focus on cutting reliance on third-party agencies and offering real-time clinical demand prediction is unique. We view this as a prime opportunity to back a category-defining clinical workforce optimization company and are excited to watch In-House lead the way in modernizing hospital staffing.”
- Blake Wu, Partner at NEA
“One of our central themes at TMV is to invest in businesses transforming the future of the healthcare workforce. The bar is very high for hospital systems to purchase outside technology. In-House Health is distinctive in that they are a win for the nurse experience as well as the hospital bottom line.”
- Soraya Darabi, Co-founder and General Partner at TMV
